Showing results (451-460 of 482) with videos related to
Sort By:
Pageof 49
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2018
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung CarcinomaHui Yu, Zhengming Chen, Karla V Ballman, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 26, 2020
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesotheliomaIsabelle Opitz, Arnaud Scherpereel, Thierry Berghmans, et al.The Journal of Thoracic and Cardiovascular Surgery|October 12, 2024
Initial patient characteristics of Thoracic Surgical Oncology Group 102: A multicenter prospective registry of active surveillance in patients with multiple ground-glass opacitiesJames Huang, Kay See Tan, Nasser Altorki, et al.Cancer Immunology Research|November 19, 2016
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive FactorsMark M Awad, Robert E Jones, Hongye Liu, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 4, 2022
A Delphi Consensus report from the "Prolonged Air Leak: A Survey" study group on prevention and management of postoperative air leaks after minimally invasive anatomical resectionsFrancesco Zaraca, Alessandro Brunelli, Marco Damiano Pipitone, et al.Nature Genetics|March 2, 2016
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterationsRaphael Bueno, Eric W Stawiski, Leonard D Goldstein, et al.Cancer Research|November 12, 2015
Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural MesotheliomaAssunta De Rienzo, Michael A Archer, Beow Y Yeap, et al.Genome Medicine|May 31, 2022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaJenette Creaney, Ann-Marie Patch, Venkateswar Addala, et al.Nature Communications|February 18, 2016
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpointsShohei Koyama, Esra A Akbay, Yvonne Y Li, et al.JCI Insight|October 5, 2016
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypesPatrick H Lizotte, Elena V Ivanova, Mark M Awad, et al.Pageof 49